General OA media and info, page-434

Good find Rod. There is no question, significant weight
loss will reduce symptoms in a weight bearing degenerative joint and these drugs will be prescribed to reduce the burden of high BMI. But I have formed a view that pps will clearly compliment this effect.

There is a gulf between symptom management and surgery in managing these injuries in society. Ie once the BMI is down, symtpoms are still there, just less. Enter (fingers crossed) Zilosul.

The multiple methods of actions of ipps will see this one through. It can safely and effectively assist (acute and) chronic bme lesions as well as assist the bodies ability to repair cartilage, manage pain and reduce the toxic soup of chronic inflammation.

Mozz speaks of our other indications, Pain, Heart Failure, Mosquite borne arthralgias, neurodegenerative disorders.

I personally wonder if the drugs effect on our quality and amount of high molecule weighted Hyralonic Acid will see this one used as an anti aging drug at some point within the decade ahead.